Litcius/Paper detail

Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)

Rui Zhou, Bo Qiu, Mai Xiong, Yimei Liu, Kangqiang Peng, Yifeng Luo, Daquan Wang, FangJie Liu, NaiBin Chen, JinYu Guo, Jun Zhang, Xiaoyan Huang, YuMing Rong, Hui Liu

2023International Journal of Radiation Oncology*Biology*Physics17 citationsDOI

Topics & Concepts

MedicineInternal medicineClinical endpointLung cancerDocetaxelChemotherapyProgression-free survivalRadiation therapyPhases of clinical researchProspective cohort studyOncologyStage (stratigraphy)Hazard ratioConfidence intervalClinical trialPaleontologyBiologyLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisRadiomics and Machine Learning in Medical Imaging
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049) | Litcius